skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Assignor Details
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Assignor Name : NAIK, KESHAV
Total Assignments: 4
Assignment: 1
Reel/Frame:024872/0193   Pages: 15
Recorded: 08/23/2010
Attorney Dkt #:3800008-00002
Conveyance: ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors
1
BHUNIYA, DEBNATH
Exec Dt:
05/31/2010
2
BHOSALE, SANDEEP BHAUSAHEB
Exec Dt:
05/24/2010
3
KAPKOTI, GOBIND SING
Exec Dt:
05/19/2010
4
PALLE, VENKATA POORNAPRAGNACHARYULU
Exec Dt:
05/20/2010
5
DE, SIDDHARTHA
Exec Dt:
06/03/2010
6
MOOKHTIAR, KASIM A.
Exec Dt:
05/24/2010
7
DAVE, BHAVESH
Exec Dt:
05/20/2010
8
DESHPANDE, ANIL
Exec Dt:
05/21/2010
9
KURHADE, SANTOSH
Exec Dt:
05/24/2010
10
KOBAL, BALASAHEB
Exec Dt:
05/24/2010
11
NAIK, KESHAV
Exec Dt:
05/26/2010
12
KANDALKAR, SACHIN
Exec Dt:
05/24/2010
Assignee
1
ADVINUS THERAPEUTICS PRIVATE LIMITED
21 & 22 PEENYA INDUSTRIAL AREA
PHASE II
BANGALORE, INDIA 560058
Property
 
Pat #
Pub #
Intl #
App #
 
 
 
 
 
 
 
 
 
 
 
8501955
US20100310493
12681845
Correspondence name and address
DAVID B. FOURNIER
P.O. BOX 1135
K&L GATES LLP
CHICAGO, IL 60690
Assignment: 2
Reel/Frame:035241/0604   Pages: 5
Recorded: 03/24/2015
Attorney Dkt #:KHURANA001
Conveyance: ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors
1
KOUL, SUMMON
Exec Dt:
03/23/2015
2
BHUNIYA, DEBNATH
Exec Dt:
03/23/2015
3
MOOKHTIAR, KASIM
Exec Dt:
03/23/2015
4
BHOSALE, SANDEEP
Exec Dt:
03/23/2015
5
KURHADE, SURESH
Exec Dt:
03/23/2015
6
NAIK, KESHAV
Exec Dt:
03/23/2015
7
VELYUTHAM, RAVIKUMAR
Exec Dt:
03/20/2015
8
SALUNKHE, VIDESH
Exec Dt:
03/23/2015
Assignee
1
ADVINUS THERAPEUTICS LIMITED
21 & 22, PEENYA INDUSTRIAL AREA
PHASE II
BANGALORE, INDIA 560 058
Property
 
Pat #
Pub #
Intl #
App #
 
 
 
 
 
 
 
 
 
 
 
9550793
US20150218187
14430469
Correspondence name and address
DAVID BRADIN
4505 EMPEROR BLVD, SUITE 330
ANDREWS KURTH LLP
DURHAM, NC 27703
Assignment: 3
Reel/Frame:041160/0103   Pages: 10
Recorded: 02/02/2017
Attorney Dkt #:2016-0706A
Conveyance: ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors
1
KOUL, SUMMON
Exec Dt:
10/19/2016
2
KURHADE, SURESH
Exec Dt:
10/20/2016
3
BHOSALE, SANDEEP
Exec Dt:
10/20/2016
4
NAIK, KESHAV
Exec Dt:
10/19/2016
5
SALUNKHE, VIDESH
Exec Dt:
10/20/2016
6
MUNOT, YOGESH
Exec Dt:
10/19/2016
7
BHUNIYA, DEBNATH
Exec Dt:
10/19/2016
Assignee
1
ADVINUS THERAPEUTICS LIMITED
21 & 22 PEENYA INDUSTRIAL AREA, PHASE II
BANGALORE, INDIA 560058
Property
 
Pat #
Pub #
Intl #
App #
 
 
 
 
 
 
 
 
 
 
 
9643967
US20170008885
15103900
Correspondence name and address
WENDEROTH, LIND AND PONACK, L.L.P.
1030 15TH STREET, NW
SUITE 400E
WASHINGTON, DC 20005
Assignment: 4
Reel/Frame:051688/0984   Pages: 13
Recorded: 01/23/2020
Attorney Dkt #:LAKS004.001APC
Conveyance: ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors
1
SHAIKH, NADIM
Exec Dt:
01/03/2020
2
THAKKAR, MAHESH
Exec Dt:
01/02/2020
3
SHINDE, SHAILESH
Exec Dt:
01/01/2020
4
JOSHI, MANOJ
Exec Dt:
01/02/2020
5
NAIK, KESHAV
Exec Dt:
01/01/2020
6
BHALERAO, AMIT
Exec Dt:
01/04/2020
7
MUKIM, MAYUR
Exec Dt:
01/02/2020
8
BHUNIYA, DEBNATH
Exec Dt:
01/03/2020
9
KULKARNI, BHEEMASHANKAR
Exec Dt:
01/02/2020
10
MOOKHTIAR, KASIM
Exec Dt:
01/07/2020
Assignee
1
IMPETIS BIOSCIENCES LIMITED
C/O TATA INDUSTRIES LTD., BOMBAY HOUSE, 1ST FLOOR, HOMI MODY STREET
MUMBAI, INDIA 400001
Property
 
Pat #
Pub #
Intl #
App #
 
 
 
 
 
 
 
 
 
 
 
11098026
US20200087281
16494239
Correspondence name and address
KNOBBE, MARTENS, OLSON & BEAR, LLP
2040 MAIN STREET
14TH FLOOR
IRVINE, CA 92614

Search Results as of: 06/08/2024 12:15 AM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT